Ibuprofen From Par Pharm With Ibuprofen 200mg Information for Drugs and Acne

The Ingredients: Ibuprofen
Dosage Form and Administration: Tablet; Oral
Drug Trade Name: Ibuprofen
Firm: Par Pharm
Strength: 200MG
New Drug Application Type: A
The Drug Application Number:71575
Medicine Product Number: 1
Approval Date: 5/8/1987
Reference Listed Drug: No
Type: DISCN
Applicant Full Name: Par Pharmaceutical Inc

Obstetrician/Gynecologist

Obstetrics and gynecology are the two surgical–medical specialties dealing with the female reproductive organs in their pregnant and non-pregnant state, respectively, and as such are often combined to form a single medical specialty and postgraduate training program. This combined training prepares the practicing OB/GYN to be adept at the surgical management of the entire scope of clinical pathology involving female reproductive organs, and to provide care for both pregnant and non-pregnant patients. Obstetrician/gynecologist is a physician specialist who provides medical and surgical care to women and has particular expertise in pregnancy, childbirth, and disorders of the reproductive system. This includes preventative care, prenatal care, detection of sexually transmitted diseases, Pap test screening, and family planning. An obstetrician is a medical doctor who specializes in the management of pregnancy, labor, and birth. Obstetricians also receive specialized education in the health of the female reproductive system and surgical care. Much of their education focuses on the detection and management of obstetrical and gynecological problems. An obstetrician/gynecologist, commonly abbreviated as OB/GYN, can serve as a primary physician and often serve as consultants to other physicians. OB/GYNs can have private practices, work in hospital or clinic settings, and maintain teaching positions at university hospitals. OB/GYNs may also work public health and preventive medicine administrations. OB/GYNs have a broad base of knowledge and can vary their professional focus. Many develop unique practices, providing high-quality health care for women. OB/GYNs may choose to specialize in the following areas: An obstetrician closely monitors their patient's health during pregnancy and delivery. They diagnose fetus abnormalities or health issues of their patient and offer healthy living advice and treatment. They see their patients on a regular basis for health consultations, ultrasounds and any of their patient's prenatal medical needs including forming a birth plan. The frequency of a patient's check up often depends on risk factors and resources. Gynecology is a branch of medicine specializing in the disorders of the female reproductive system. Modern gynecology deals with menstrual disorders, menopause, infectious disease and development of the reproductive organs, disturbances of the sex hormones, benign and malignant tumor formation, and the prescription of contraceptive devices. A branch of gynecology, reproductive medicine, deals with infertility and utilizes artificial insemination and in-vitro fertilizations, a human egg fertilized in a test tube, and then implanted into the womb. Some gynecologists also practice obstetrics. Surgical gynecology began to make progress in the 19th century, when the introduction of anesthesia and antisepsis (see antiseptic) paved the way for many advances. The American physician J. M. Sims was largely responsible for gaining acceptance of gynecology as a medical and surgical specialty. Until then there had been opposition to it on moral grounds from midwives, the clergy and the medical profession.

Drug Abuse Treatment for Criminal Justice Populations

Findings show unequivocally that providing comprehensive drug abuse treatment to criminal offenders works, reducing both drug abuse and criminal recidivism. Given the swelling prison population, attributable in large part to offenses related to drug use accompanied by high rates of recidivism, it is a matter of public health and safety to make drug abuse treatment a key component of the criminal justice system. Addressing the treatment needs of substance abusing offenders is critical to reducing overall crime and other societal burdens related to drug abuse, such as lost job productivity.
Scientific research shows that drug abuse treatment can work even when an individual enters it under legal mandate. However, only a small percentage of those who need treatment actually receive it and often treatment itself is not sufficient. To be effective, treatment must begin in prison and continue after release by means of participation in community treatment programs. By engaging in an ongoing therapeutic process, people can learn how to avoid relapse and withdraw from a life of crime.

Drug Abuse Crime Connection

It is easy to see the connection between drug abuse and crime. Drug abuse is criminal in the following ways: drug possession or sales; to drug abuse e.g., stealing to get money for drugs; and a drug abuse lifestyle that predisposes the drug abuser to engage in illegal activity, like associating with other offenders or dealing in illicit markets. Individuals who use illicit drugs are more likely to commit crimes and it is common for individuals who had used drugs or alcohol to commit many offenses, including violent crimes.
After a nationally representative survey of state correctional agencies in 2005, Criminal Justice Drug Abuse Treatment Studies (CJ–DATS) investigators estimated that nearly 8 million adults were involved in the justice system (Taxman, Young, Wiersema, et al., 2007). Almost 5 million individuals are on probation or under parole supervision (Glaze and Bonczar, 2006; Taxman, Young, Wiersema, et al., 2007), with drug law violators accounting for the largest percentage of these parolees. The substance abuse or dependence rates of offenders are more than four times that of the general population (National Institute of Justice, 2003; U.S. Department of Health and Human Services, 2006). In a 2004 survey, the Bureau of Justice Statistics BJS estimated that about 53 percent of state and 45 percent of federal prisoners met Diagnostic and Statistical Manual for Mental Disorders (DSM) criteria for drug abuse or dependence (Mumola and Karberg, 2006). Of those surveyed, 14.8 percent of state and 17.4 percent of federal prisoners reported having drug treatment since admission (Mumola and Karberg, 2006). Juvenile justice systems also report high levels of drug abuse. A survey of juvenile detainees in 2000 found that about 56 percent of the boys and 40 percent of the girls tested positive for drug use at the time of arrest (National Institute of Justice, 2003).
Although there has been an increased interest in providing substance abuse treatment services for criminal justice offenders, in the last decade, only a small percentage of offenders have access to adequate services, especially in jails and community correctional facilities (Taxman, Perdoni and Harrison, 2007). Not only is there a gap in the availability of these services for offenders, but often there are few choices in the types of services provided. Treatment is of insufficient quality and intensity or is not well suited to the needs of offenders and may not yield meaningful reductions in drug use and recidivism. Untreated substance abusing offenders are more likely to relapse to drug abuse and return to criminal behavior than treated offenders. Relapse can bring about re-arrest and re-incarceration, jeopardizing public health and public safety and taxing criminal justice system resources. Treatment offers the best alternative for interrupting the drug abuse/criminal justice cycle for offenders with drug abuse problems.
Drug abuse treatment can be incorporated into criminal justice settings in a variety of ways. These include treatment as a condition of probation; drug courts that blend judicial monitoring and sanctions with treatment; treatment in prison followed by community-based treatment after release; and treatment under parole or probation supervision. Actual drug abuse treatment efficiency can benefit from the cross-agency coordination and collaboration of criminal justice professionals, substance abuse treatment providers and other social service agencies. By working together, the criminal justice and treatment systems can optimize resources to benefit the health, safety and wellbeing of the individuals and communities they serve.

Drug Addiction Affects Behavior

Drug addiction is a brain disease that affects behavior. Drug addiction has cognitive, behavioral and physiological characteristics that contribute to continued drugs use despite the harmful consequences. Scientists have found that chronic drug abuse alters the anatomy and chemistry of the brain and that these changes can last for months or years after the individual has stopped using drugs. This transformation may help explain why addicts are at a high risk of relapse to drug abuse even after long periods of abstinence and why addicts persist in seeking drugs despite deleterious consequences.

Treatment Helps Recovery

Recovery from drug addiction requires effective treatment, followed by management of the problem over time. Drug addiction is a serious problem that can be treated and managed throughout its course. Effective drug abuse treatment engages the participant in a therapeutic process, retains the user in treatment for an appropriate length of time and helps the addict learn to maintain abstinence over time. Addicts may require multiple episodes of treatment. Outcomes for drug abusing offenders in the community can be improved by monitoring drug use and by encouraging continued participation in treatment.

Effective Treatment Duration

Treatment must last long enough to produce stable behavioral changes. In treatment, the drug abuser is taught to break old patterns of thinking and behaving and to learn new skills for avoiding drug use and criminal behavior. Individuals with severe drug problems and co-occurring disorders typically need longer treatment e.g., a minimum of 3 months and more comprehensive services. Early in treatment, the drug abuser begins a therapeutic process of change. In later stages, the individual addresses other problems related to drug abuse and learns how to manage the problem.

Assessment is the First Step in Treatment

A history of drug or alcohol use may suggest the need for a specialist to conduct a comprehensive assessment to determine the nature and extent of the drug problems of an individual, and establish whether problems exist in other areas that may affect recovery and enable the formulation of an appropriate treatment plan. Personality disorders and other mental health problems are prevalent in offender populations. Comprehensive assessments should include mental health evaluations with treatment techniques that plan for these problems.

Services to Fit Criminal Needs

Tailoring services to fit the needs of the individual is an important part of effective drug abuse treatment for criminal justice populations. Individuals differ in terms of age, gender, ethnicity and culture, problem severity, recovery stage and level of supervision needed. Individuals also respond differently to different treatment approaches and treatment providers. In general, drug treatment should address issues of motivation, problem solving and skill-building for resisting drug use and criminal behavior. Lessons aimed at supplanting drug use and criminal activities with constructive activities and at understanding the consequences of behavior are important. Treatment interventions can facilitate the development of healthy interpersonal relationships and improve the ability of the participant to interact with family, peers and others in the community.

Monitoring Treatment of Criminal Drug Abusers

Specialists should carefully monitor drug abuser during treatment. Individuals trying to recover from drug addiction may experience a relapse or return to drug use. Triggers for drug relapse vary. Common triggers are mental stress and associations with peers and social situations linked to drug use. An undetected relapse can progress to serious drug abuse, but detected drug use can present opportunities for therapeutic intervention. Monitoring drug use through urinalysis or other objective methods, as part of treatment or criminal justice supervision, provides a basis for assessing and providing feedback on the treatment progress. It also provides opportunities for specialists to intervene to address unconstructive behavior. Specialists can determine rewards and sanctions to facilitate change and modify treatment plans according to progress.

Offender Target Factors

Drug abuse treatment should target factors that link to criminal behavior. Criminal thinking is a combination of attitudes and beliefs that support a criminal lifestyle and criminal behavior. Criminal thinking can include feelings of being entitled; feeling that criminal behavior is justified; failing to be responsible for actions; and consistently failing to anticipate or appreciate the consequences of behaviors. Criminal thinking is a pattern of thinking that often contributes to drug use and criminal behavior. Treatment that provides specific cognitive skills training to help individuals recognize errors in judgment that lead to drug abuse and criminal behavior may improve recovery from drug abuse.

Criminal Justice Supervision

Criminal justice supervision should incorporate treatment planning for drug abusing offenders and treatment providers should be aware of correctional supervision requirements. The coordination of drug abuse treatment with correctional planning can encourage participation in drug abuse treatment and can help treatment providers incorporate correctional requirements as treatment goals. Treatment providers should collaborate with criminal justice staff to evaluate individual treatment plans and ensure that each plan meets correctional supervision requirements, as well as to ensure the changing needs of each individual, which sometimes includes housing and childcare; medical, psychiatric and social support services; and vocational and employment assistance. For offenders with drug abuse problems, a treatment plan should incorporate the transition to community-based treatment and links to appropriate post-release services to improve the success of drug treatment and return to society. Abstinence requirements may necessitate a rapid clinical response, such as more counseling, targeted intervention or increased medication, in order to prevent relapse. Ongoing coordination between treatment providers and courts or parole and probation officers is important in addressing the complex needs of these individuals.

Continuity of Care

Continuity of care is essential for drug abusers re-entering the community. Drug users who complete treatment in prison and continue with treatment in the community have low relapse rates. Continuing drug abuse treatment helps released offender deal with problems that become relevant only after prison, such as learning to handle situations that could lead to relapse, learning how to live without drugs in the community and how to develop a peer support network. Treatment in prison or jail can begin a process of therapeutic change, resulting in reduced drug use and criminal behavior after incarceration. Continuing drug treatment in the community is essential to sustaining abstinence.

Balanced Approach

A balance of rewards and sanctions encourages positive social behavior and treatment participation. When providing correctional supervision of individuals participating in drug abuse treatment, it is important to reinforce positive behavior. Nonmonetary social rewards such as recognition for progress or sincere effort are effective, as are graduated sanctions that are consistent, predictable and clear responses to noncompliant behavior. Generally, treatment specialists implement less punitive responses for early and less serious noncompliance, with increasingly severe sanctions issued for continued problem behavior. Rewards and sanctions are most likely to have the desired effect when they are fair and when they swiftly follow the targeted behavior.

Co-Occurring Drug Abuse and Mental Health

Offenders with co-occurring drug abuse and mental health problems often require an integrated treatment approach. High rates of mental health problems are present in offender populations and in those with substance abuse problems. Drug abuse treatment can sometimes address depression, anxiety and other mental health problems. Personality, cognitive and other serious mental disorders can be difficult to treat and may disrupt drug treatment. The presence of co-occurring disorders may require an integrated approach that combines drug abuse treatment with psychiatric treatment, including the use of medication. A physician should assess Individuals with either a substance abuse or mental health problem for the presence of the other.

Medications for Drug Abuse

Medications are important parts of treatment for many drug abusing offenders. For heroin addiction, medicines such as methadone and buprenorphine help normalize brain function and individuals who may benefit from them should take them. Effective use of medications can be instrumental in enabling people with co-occurring mental health problems to function successfully in society. Behavioral strategies can increase adherence to medication regimens.

Chronic Conditions Prevention

Treatment planning for drug abusing offenders who are living in or returning the community should include strategies to prevent and treat serious, chronic medical conditions, such as HIV/AIDS, hepatitis B and C and tuberculosis.
The rates of infectious diseases, such as hepatitis, tuberculosis and HIV/AIDS, are higher in drug abusers, incarcerated offenders and offenders under community supervision than in the general population. Infectious diseases affect not just the offender, but also the criminal justice system and the wider community. Consistent with federal and state laws, offenders who have abused drugs should be tested for infectious diseases and receive counseling on health practices and on ways to modify risky behaviors. Probation and parole officers who monitor offenders with serious medical conditions should link them with appropriate healthcare services, encourage compliance with medical treatment and re-establish eligibility of the offender for public health services like Medicaid.

Offender Risk factors

Potential risk factors for released offenders include pressures from peers and family members to return to drug use and a criminal lifestyle. The tensions of daily life, like violent associates, few opportunities for legitimate employment, lack of safe housing, even the need to comply with correctional supervision conditions, can also create stressful situations that can precipitate a relapse to drug use.
Research on how drug abuse affects the brain promises to uncover more about the mechanics of brain changes and its relationship to drug addiction. Research also reveals that with effective drug abuse treatment, individuals can overcome persistent drug effects and lead healthy, productive lives.

Drug Abuse Treatment for Offenders

The case for treating drug abusing offenders is compelling. Drug abuse treatment improves the quality of life for drug abusing offenders and has beneficial effects for public health and safety. Effective treatment decreases future drug use and criminal behavior related to drug use, and can improve the relationships of the individual with family and may improve prospects for employment.
Outcomes for substance abusing individuals improve when criminal justice personnel work in tandem with treatment providers on drug abuse treatment needs and supervise patient requirements. Rehabilitation experts assess the treatment needs of the offender after arrest. Assessments often include substance abuse severity, mental health problems and physical health. Defense attorneys, prosecutors and judges need to work together during the prosecution and sentencing phases of the criminal justice process to determine suitable treatment programs that meet the needs of the offender. Through drug courts, diversion programs, pretrial release programs conditional on treatment and conditional probation with sanctions, the offender can participate in drug abuse treatment in the community while under criminal justice supervision. In some instances, the judge may recommend that the offender participate in treatment while serving jail or prison time or require it as part of continuing correctional supervision post release.

Drug Abuse Treatment for Criminals

Drug abuse treatment is an effective intervention for drug abusers, including those who are involved with the criminal justice system. However, the effectiveness of drug treatment depends on both the individual and the program and on whether interventions and treatment services are available and appropriate for the needs of the individual. To amend attitudes, beliefs and behaviors that support drug use, the drug abuser must engage in a therapeutic change process. Longitudinal outcome studies find that those who participate in drug abuse treatment programs in the community commit fewer crimes than those who do not participate.
A history of drug use does not indicate the need for drug abuse treatment. Offenders who meet drug dependence criteria should have higher priority for treatment than those who do not. Less intensive interventions, such as drug abuse education or self help participation, may be appropriate for those not meeting criteria for drug dependence.
Some drug abuse treatments programs tailor to the needs of juveniles. Some programs offer psychiatric treatment. All drug abuse treatment programs become more effective when criminal or cognitive behavioral criminal justice personnel work in tandem with treatment providers.
If drug abusers meet other criteria, low motivation to participate in treatment or to end drug abuse should not preclude access to treatment. Motivational enhancement interventions may be useful in these cases. Examples of motivation include motivational interviewing and contingency management techniques, which often provide tangible rewards.

Offender Legal Pressures

Legal pressure that encourages abstinence and treatment participation may also help individuals by improving retention and catalyzing longer treatment stays.
Drug abuse treatment is effective for offenders who have a history of serious and violent crime, particularly with intensive, targeted services. The economic benefits in avoided crime and costs to crime victims, like medical costs, lost earnings and loss in quality of life, may be substantial for these higher risk offenders. Treating them requires a high degree of coordination between drug abuse treatment providers and criminal justice personnel in order to ensure that the treatment and criminal genic meet the needs of the individual.

Legally Mandated Treatment

Often the criminal justice system can apply legal pressure to encourage offenders to participate in drug abuse treatment; or judges can mandate treatment through a drug court or as a condition of pretrial release, probation or parole. A large percentage of individuals admitted to drug abuse treatment cite legal pressure as an important reason for seeking treatment. Most studies suggest that outcomes for those who are legally pressured to enter treatment are as good as or better than outcomes for those who entered treatment without legal pressure. Those under legal pressure also tend to have higher attendance rates and to remain in treatment for longer periods, which can also have a positive impact on treatment outcomes.

Offender Risk Factors

Often, drug abusing offenders have problems in other areas. Examples include family difficulties, limited social skills, educational and employment problems, mental health disorders, infectious diseases and other medical problems. Treatment should take these problems into account, because they can increase the risk of drug relapse and criminal recidivism if left unaddressed.
Stress is often a contributing factor to relapse and offenders who enter society after incarceration face many challenges and stressors, including reuniting with family members, securing housing and complying with criminal justice supervision requirements. The daily decisions that most people face can be stressful for those recently released from a prison environment.
Other threats to recovery include a loss of support from family or friends. Drug abusers returning to the community may also encounter family, friends or associates still involved in drugs or crime. These people may entice the individual to resume a criminal and drug using lifestyle. Returning to environments or activities associated with prior drug use may trigger strong cravings and cause a relapse. A coordinated approach by treatment and criminal justice staff provides the best way to detect and intervene with these and other threats to recovery. In any case, treatment provides the skills necessary to avoid or cope with situations that could lead to relapse.
Treatment staff should identify the unique relapse risk factors of every offender and periodically re-assess and modify treatment plans as needed. Generally, continuing or recurring drug use during treatment requires a clinical response by either increasing the dosage or level of treatment or changing the treatment intervention.

Health Services Criminal Abusers

One of the goals of treatment planning is to match interventions to individual needs at each stage of drug treatment. Over time, individuals may need various combinations of treatment services. Evidence-based interventions include: cognitive behavioral therapy to help participants learn positive social and coping skills; contingency management approaches to reinforce positive behavioral change; and motivational enhancement to increase treatment engagement and retention. In those addicted to opioid drugs, agonist or partial agonist medications can also help normalize brain function and antagonist medications can facilitate abstinence. For juvenile offenders, treatments that involve the family and other aspects of the drug abuser environment show efficacy.
Drug abuse treatment plans for incarcerated offenders can anticipate the eventual return of the individual to the community by incorporating relevant transition plans and services. Drug abuser treatment often includes mental and physical health services; family counseling; parenting, educational and vocational services, and is crucial components of successful treatment. Case management approaches provide assistance in obtaining drug abuse treatment and community services.

Offender Treatment Duration

While individuals progress through drug abuse treatment at different rates, one of the most reliable findings in treatment research is that length of treatment relates directly to lasting reductions in criminal activity and drug abuse. Generally, better outcomes occur from treatment lasting longer than 90 days, with the greatest reductions in drug abuse and criminal behavior accruing to those who complete treatment. Again, legal pressure can improve retention rates.
A longer continuum of treatment is best for individuals with severe or multiple problems. Research shows that participation in a therapeutic community in prison followed by treatment in the community after prison release can reduce the risk of recidivism to criminal behavior as well as relapse to drug use.

Offender Relapse

Because addiction is a chronic disease, drug relapses and returns to treatment are common features of the path to recovery, so treatment should extend over a long period of time and across multiple episodes of care. Individuals with the most severe problems can participate in treatment and achieve positive outcomes.

Rewards and Sanctions in Offender Treatment

The systematic application of behavioral management principles that underscore reward and punishment can help individuals reduce drug use and criminal behavior. Rewards and sanctions change behavior when they follow targeted behavior, swiftly and fairly. It is important to recognize and force progress toward abstinent behavior. Rewarding positively toward responsible, behavior is more effective in producing abstinent behavior. Long term positive change is better than punishing negative behavior. Nonmonetary rewards such as social recognition can be as effective as monetary rewards. A graduated range of rewards given for meeting predetermined goals can be an effective strategy.
In recovery treatments in the community, contingency management strategies use incentives or rewards, like vouchers or bus tokens, to reinforce abstinence measured by negative drug tests or to shape progress toward other treatment goals, such as program session attendance or compliance with medication regimens. Contingency management is most effective when the contingent reward closely follows the behavior monitored. Graduated sanctions, which invoke less punitive responses for early and less serious noncompliance and increasingly severe sanctions for more serious or continuing problems, are effective tools in conjunction with drug testing. The effective use of graduated sanctions involves consistent, predictable and clear responses to noncompliant behavior.

Drug Testing

Drug testing can determine when an individual is having difficulties with recovery. The first response to drug use is clinical and detected through urinalysis and results in an increase in treatment intensity or a change to an alternative treatment. This often requires coordination between the criminal justice staff and the treatment provider. A more intensive treatment approach should not be a sanction, but rather a routine progression in healthcare practice when a treatment appears less effective than expected.
Behavioral contracting can employ both rewards and sanctions. A behavioral contract is an explicit agreement between the participant and the treatment provider or criminal justice monitor or among all three. A behavioral contract specifies proscribed behaviors and associated sanctions, as well as positive goals and rewards for success. Behavioral contracting can instill a sense of procedural justice because both the necessary steps toward progress and the sanctions for violating the contract are specific and understood in advance.

Treatment Medications

Medications can be an important component of effective drug abuse treatment for offenders. By allowing the body to function normally, prescription medications enable the addict to leave behind a life of crime and drug abuse. For example, opioid agonist and partial agonist medications, which act at the same receptors as heroin, morphine and natural brain endorphins, are effective at helping an individual remain in treatment. Antagonist medications, which work by blocking the effects of a drug, are effective but patients do not often take the drugs regularly. Despite evidence of the effectiveness of medicines, doctors prescribe addiction medications but patients underutilize them in the treatment of drug abusers within the criminal justice system. Still, some jurisdictions have found ways to successfully implement medication therapy for drug abusing offenders.

Opiates Heroin

Long term opiate abuse results in a desensitization of the opiate receptors to endorphins in the brain. Endorphins are natural opioids in the body. Methadone acts on the same receptors as the natural endorphins, stabilizing the craving that otherwise results in compulsive use of heroin or other illicit opiates. Methadone effectively reduces opiate use, criminal behavior related to drugs and risky HIV behaviors. Buprenorphine is a partial agonist and acts on the same receptors as morphine, a full agonist, but without producing the same level of dependence or withdrawal symptoms. Suboxone® is a unique formulation of buprenorphine that contains naloxone, an opioid antagonist, which limits diversion by causing severe withdrawal symptoms in those who inject it to get high, but has no adverse effects when taken orally, as prescribed. Naltrexone, an opiate antagonist, blocks the effects of opiates.

Alcohol

Disulfiram also known as Antabuse is an aversion therapy that induces nausea when a person consumes alcohol. Acamprosate works by restoring normal balance to the glutamate neurotransmitter system in the brain, helping to reduce alcohol cravings. The Food and Drug Administration (FDA) approves the use of Naltrexone, which blocks some of the pleasurable effects of alcohol.

Infectious Diseases among Drug Abusing Offenders

It is critical for the criminal justice and drug abuse treatment systems to work together and combine efforts to reduce the spread of HIV/AIDS and other infectious diseases, which occur at higher rates among drug abusers in the criminal justice system than among the general population. The prevalence of AIDS is approximately five times higher among incarcerated offenders than in the general population. In addition, individuals in the criminal justice system represent a significant portion of hepatitis B, hepatitis C and tuberculosis cases in the United States. Although most people contract infectious diseases in the community and not in correctional settings, the correctional setting must treat these infectious diseases once diagnosed.
Infectious diseases among offenders who re-enter or live within the community present a serious public health challenge. While incarcerated, offenders often have access to adequate healthcare, which offers opportunities for integrating strategies to address medical, mental health and drug abuse problems. Doctors should link offenders with infectious diseases who return to the community with medical care facilities within the community before release. Community health, drug treatment and criminal justice agencies should work together to offer education, screening, counseling, prevention and treatment programs for HIV/AIDS, hepatitis and other infectious diseases to offenders in or returning to the community. Drug abuse treatment can decrease the spread of infectious disease by reducing risky behaviors such as needle sharing and unprotected sex.
The need to negotiate access to health services and adhere to complex treatment protocols places a large burden on the addicted offender and many offenders fall through the cracks. Untreated or deteriorating medical or mental health problems increase the risk of relapse to drug abuse and to possible arrest and incarceration, again.

Substance Abuse and Mental Disorders

It is important to adequately assess mental disorders and to address these diseases as part of effective drug abuse treatment. Specialists can address many types of mental health problems in standard drug abuse treatment programs. However, individuals with serious mental disorders may require an integrated treatment approach designed for treating patients with co-occurring mental health problems and substance use disorders. Although not readily available, specialized therapeutic community Mentally Ill Chemical Abuser programs (MICA) attend to patients with co-occurring mental and addictive problems.
Science has progressed by developing effective medications for treating mental disorders, including a number of antidepressants, anti anxiety agents, mood stabilizers and antipsychotics. These medications may be critical for treatment success in offenders who have co-occurring mental disorders such as depression, anxiety disorders, bipolar disorder or schizophrenia. Cognitive behavioral therapy can be effective for treating some mental health problems, particularly when combined with medications. Contingency management can improve adherence to medications and intensive case management is useful for linking severely mentally ill individuals with drug abuse treatment, mental health care and community services.

Drug Abuse Treatment to Offenders Return on Investment (ROI)

In 2002, the estimated cost to society of drug abuse was $180.9 billion (Office of National Drug Control Policy [ONDCP], 2004), $107.8 billion related to crime related to drugs, including criminal justice system costs and costs borne by victims of crime. The cost of treating drug abuse including research, training and prevention efforts is about $15.8 billion, a fraction of these overall societal costs (ONDCP, 2004).
Drug abuse treatment is cost effective in reducing drug use and bringing about associated healthcare, crime and incarceration cost savings. Positive net economic benefits are consistently found for drug abuse treatment across various settings and populations. The largest economic benefit of treatment is in avoided costs of crime, incarceration and victimization costs, with greater economic benefits resulting from treating offenders with co-occurring mental health problems and substance use disorders. Residential prison treatment is more cost effective if offenders attend treatment after release, according to research (Martin, Butzin, Saum and Inciardi, 1999). Drug courts also convey positive economic benefits, including allowing participants to earn wages and avoid incarceration and future crime costs.
Incarcerated women have high rates of substance abuse, mental disorders and other health problems.

Treatment Needs for Women in the Criminal Justice System

Although women face incarceration at far lower rates than men, the number and percentage of incarcerated women have grown substantially in recent years. Between 1995 and 2005, the number of men in prisons and jails grew by about a third, while the number of incarcerated women more than doubled (Harrison and Beck, 2006). Women in prison are likely to have a different set of problems and needs than men, which present particular treatment challenges. For example, compared to incarcerated men, incarcerated women in treatment are significantly more likely to have severe substance abuse histories, as well as physical health and psychological problems (Messing, Burdon, Hagopian and Prendergast, 2006). Approximately 50 percent of female offenders are likely to have histories of physical or sexual abuse. Women are also more likely than men to be victims of domestic violence. Past or current victimization can contribute to drug or alcohol abuse, depression, post traumatic stress disorder and criminal activity.
Treatment programs serving both men and women offer effective treatment for female clients. However, programs specific to each gender may be more effective for female offenders, particularly those with histories of trauma and abuse. Female offenders are more likely to need medical and mental health services, childcare services and assistance in finding housing and employment. Following a comprehensive assessment, women with mental health disorders should receive appropriate treatment and case management, including victim services as needed. For female offenders with children, parental responsibilities can conflict with the ability to participate in drug treatment. Regaining or retaining custody of children can also motivate mothers to participate in treatment. Treatment programs may improve retention by offering childcare services and parenting classes.

Juveniles Abusers in the Criminal Justice System

In recent years, there number of juveniles with substance abuse problems involved in the criminal and juvenile justice systems is up. From 1986 to 1996, juvenile incarcerations related to drug use increased nearly threefold. In 2002, about 60 percent of detained boys and nearly half of the girls tested positive for drug use. One study found that about one-half of both male and female juvenile detainees met criteria for a substance use disorder (Teplin, Abram, McClelland, et al., 2002). Juveniles entering the criminal justice system can bring a number of serious issues with them including: substance abuse; academic failure; emotional disturbances; physical health issues; family problems and a history of physical or sexual abuse. Girls make up nearly a third of juvenile arrests, a high percentage report some form of emotional, physical or sexual abuse. Effectively addressing these issues requires the juvenile gaining access to comprehensive assessment, treatment, case management and support services that are age and developmentally appropriate. Assessment is particularly important, because not all adolescents who use drugs need treatment. For those who do, there are several points in the juvenile justice continuum where treatment is available, including juvenile drug courts, supervision within the community and juvenile detention.
Families play an important role in the recovery of substance abusing juveniles, but this influence can be positive or negative. Parental substance abuse or criminal involvement, physical or sexual abuse by family members and lack of parental involvement or supervision are all risk factors for adolescent substance abuse and delinquent behavior. Thus, the effective treatment of juvenile substance abusers often requires a treatment model that targets family functioning and the increased involvement of family members. Effective adolescent treatment approaches include multi-systemic therapy, multidimensional family therapy and functional family therapy. These interventions show promise in strengthening families and decreasing juvenile substance abuse and delinquent behavior.